Quote For Par Pharmaceutical Companies, Inc. PRX.N

Par Pharmaceutical Companies, Inc. (PRX.N) (New York Stock Exchange)
sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·
As of  27 Nov 2009
23.89USD
Price Change
-0.38
Percent Change
-1.57%
 
Research a stock:   symbol lookup
$23.89
27 Nov 2009
-1.57%
$23.89
--
206,666
$24.15
$23.49
$24.60
$8.57
0.75
534,895

News

Press Releases

Key Developments

Officers

Name Current Position Compensation
LePore, Patrick Chairman of the Board, President, Chief Executive Officer 2,577,348
Kenyon, Lawrence Chief Financial Officer, Executive Vice President --
Haughey, Thomas Executive Vice President, Chief Administrative Officer, General Counsel, Secretary 1,651,643

Key Ratios and Statistics

Share Related Items
Market Cap (Mil.) $831.83
Shares Outstanding (Mil.) 34.82
Float (Mil.) 34.00
Dividend Information
Yield % -99,999.99
Annual Dividend ($ USD) 0.00
Payout Ratio(TTM) % 0.00
Financial Strength
Quick Ratio 1.49
Current Ratio 2.12
LT Debt/Equity 0.00
Total Debt/Equity 15.38
Valuation Ratios
Price/Earnings(TTM) 22.66
Price/Sales(TTM) 0.78
Price/Book(TTM) 1.72
Price/Cash Flow(TTM) 11.31
Per Share Data
Earnings(TTM) $1.07
Sales(TTM) $31.49
Book Value(MRQ) $13.88
Cash Flow(TTM) $2.18
Cash(MRQ) $6.04
Management Effectiveness
Return on Equity(TTM) 7.93
Return on Assets(TTM) 4.77
Return on Investment(TTM) 7.34
Margins
Gross Margin(TTM) % 26.43
Operating Margin(TTM) % 5.06
Profit Margin(TTM) % 3.41

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement